Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering.
This report contains a comprehensive listing of 887 artificial intelligence deals announced since 2019 including financial terms where available including links to online deal records of actual artificial intelligence partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
Fully revised and updated, the report provides details of artificial intelligence deals from 2019 to 2024. The report provides a detailed understanding and analysis of how and why companies enter artificial intelligence deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. The report includes collaboration, development, research and licensing deals.
Artificial Intelligence (AI) Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the artificial intelligence deals entered into by the world's leading biopharma companies.
- Understand deal trends since 2019
- Browse artificial intelligence collaboration and licensing deals
- Benchmark analysis - identify market value of transactions
- Financials terms - upfront, milestone, royalties
- Directory of deals by company A-Z, deal type and therapy area
- Leading deals by value
- Most active dealmakers
- Identify assets and deal terms for each transaction
- Access contract documents - insights into deal structures
- Due diligence - assess suitability of your proposed deal terms for partner companies
- Save hundreds of hours of research time
The initial chapters of this report provide an orientation of artificial intelligence dealmaking.
Chapter 1 provides an introduction to the report.
Chapter 2 provides an overview of the trends in artificial intelligence dealmaking since 2019.
Chapter 3 provides an overview of the leading artificial intelligence deals since 2019. Deals are listed by headline value.
Chapter 4 provides a comprehensive listing of the top 25 most active companies in artificial intelligence dealmaking with a brief summary followed by a comprehensive listing of artificial intelligence deals, as well as contract documents available in the public domain.
Chapter 5 provides a comprehensive and detailed review of artificial intelligence deals signed and announced since Jan 2019, where a contract document is available in the public domain.
Chapter 6 provides a comprehensive and detailed review of artificial intelligence partnering deals signed and announced since Jan 2019. The chapter is organized by specific artificial intelligence technology type in focus.
Report Scope
Artificial Intelligence (AI) Collaboration and Licensing Deals includes:
- Trends in artificial intelligence dealmaking in the biopharma industry
- Directory of artificial intelligence deal records covering pharmaceutical and biotechnology
- The leading artificial intelligence deals by value
- Most active artificial intelligence licensing dealmakers
Analyzing contract agreements allows due diligence of:
- What are the precise rights granted or optioned?
- What is actually granted by the agreement to the partner company?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are IPRs handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes to be resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in artificial intelligence dealmaking
2.1. Introduction
2.2. Artificial intelligence deals over the years
2.3. Most active artificial intelligence dealmakers
2.4. Artificial intelligence deals by deal type
2.5. Artificial intelligence deals by therapy area
2.6. Artificial intelligence deals by industry sector
2.7. Deal terms for artificial intelligence deals
2.7.1 Artificial intelligence deals headline values
2.7.2 Artificial intelligence deal upfront payments
2.7.3 Artificial intelligence deal milestone payments
2.7.4 Artificial intelligence royalty rates
Chapter 3 - Leading artificial intelligence deals
3.1. Introduction
3.2. Top artificial intelligence deals by value
Chapter 4 - Most active artificial intelligence dealmakers
4.1. Introduction
4.2. Most active artificial intelligence dealmakers
4.3. Most active artificial intelligence deals company profiles
Chapter 5 - Artificial intelligence contracts dealmaking directory
5.1. Introduction
5.2. Artificial intelligence contracts dealmaking directory
Chapter 6 - Artificial intelligence dealmaking by technology type
Deal directory
- Deal directory - Artificial intelligence deals by company A-Z
- Deal directory - Artificial intelligence deals by deal type
- Deal directory - Artificial intelligence deals by therapy area
For more information about this report visit https://www.researchandmarkets.com/r/w18h0r
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
